Some doctors prescribe sublingual immunotherapy, known as SLIT, a serum taken as drops under the tongue. Patients like it, but it is not FDA-approved, so insurance usually doesn't cover it.
Physician Siddhartha Mukherjee explains how cellular science could lead to breakthroughs in the treatment of cancer, HIV, Type 1 diabetes and sickle cell anemia. His new book is The Song of the Cell.
James P. Allison and Tasuku Honjo were cited for their work in harnessing the immune system to arrest the development of cancer.
After trying one treatment after another for his leukemia, 20-year old Aaron Reid enrolled in a study to test an experimental therapy using modified cells from his own body.
Researchers are working on better ways to teach patients' immune systems to root out and kill malignant cells. A promising approach involves cells that attack cancer two ways at one time.
Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.
An experimental therapy seems to have eradicated cancer in a patient with metastatic breast cancer who had failed every other treatment. The goal is to reliably repeat that success in more people.
Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who only got chemotherapy.
An advisory panel to the Food and Drug Administration recommends the agency, for the first time, approve a new kind of treatment that uses genetically modified immune cells to attack cancer cells.
Some hospitals and oncology practices are setting up urgent care sites tailored to the needs of cancer patients, to help keep them out of the emergency room when complications or side effects arise.